BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4505425)

  • 1. Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour.
    Rouse BT; Röllinghoff M; Warner NL
    Nat New Biol; 1972 Jul; 238(82):116-7. PubMed ID: 4505425
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of heterologous antithymocyte sera in mice. IV. Alteration of the growth rate of plasma cell tumors.
    Mandel MA; DeCosse JJ
    J Immunol; 1969 Dec; 103(6):1288-93. PubMed ID: 5361565
    [No Abstract]   [Full Text] [Related]  

  • 3. Requirement of thymus (T) lymphocytes for resistance to listeriosis.
    Lane FC; Unanue ER
    J Exp Med; 1972 May; 135(5):1104-12. PubMed ID: 4623315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 5. Assembly and secretion of immunoglobulin M (IgM) by plasma cells and lymphocytes.
    Parkhouse RM
    Transplant Rev; 1973; 14():131-44. PubMed ID: 4728819
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated immunity in vitro against syngeneic mouse plasma tumour cells.
    Wagner H; Röllinghoff M
    Nat New Biol; 1973 Jan; 241(106):53-4. PubMed ID: 4540590
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant-induced thymus-derived suppressor cells of cell-mediated tumour immunity.
    Glaser M
    Nature; 1978 Oct; 275(5681):654-6. PubMed ID: 212680
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Natl Cancer Inst; 1974 Jan; 52(1):147-52. PubMed ID: 4204244
    [No Abstract]   [Full Text] [Related]  

  • 9. Cells involved in the graft-versus-host reaction in vitro.
    Kerckhaert JA; Benner R; Willers JM
    Immunology; 1973 Jul; 25(1):103-10. PubMed ID: 4146658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunity and serum factors in plasmocytomas in mice].
    Lespinats G; Poupon MF; Kolb JP
    Bull Cancer; 1972; 59(4):353-62. PubMed ID: 4668253
    [No Abstract]   [Full Text] [Related]  

  • 11. Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas.
    Padarathsingh ML; McCoy JL; Dean JH; Lewis DD; Northing JW; Law LW
    J Natl Cancer Inst; 1977 Jun; 58(6):1701-7. PubMed ID: 301196
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of antithymocyte serum and thymectomy on the growth of tumors induced by bovine adenovirus type 3.
    Fukui H
    Acta Med Okayama; 1973 Apr; 27(1):53-69. PubMed ID: 4271878
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking effect of the migration-inhibition reaction by sera from immunized syngeneic mice and by sera from plasmacytoma-bearing BALB-c mice. Detection of free, circulating tumor antigen.
    Poupon MF; Lespinats G; Kolb JP
    J Natl Cancer Inst; 1974 Apr; 52(4):1127-34. PubMed ID: 4826584
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen recognition by T lymphocytes. II. Similar effects of azathioprine, antilymphocyte serum, and anti-theta serum on rosette-forming lymphocytes in normal and neonatally thymectomized mice.
    Bach JF; Dardenne M
    Cell Immunol; 1972 Jan; 3(1):11-21. PubMed ID: 5061822
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulin and theta-bearing murine leukemias and lymphomas.
    Shevach EM; Stobo JD; Green I
    J Immunol; 1972 May; 108(5):1146-51. PubMed ID: 4112916
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-inhibitory effect of antiplasma cell serum.
    Jagarlamoody SM; McKhann CF
    Surgery; 1972 Jul; 72(1):149-54. PubMed ID: 4555923
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine receptor-bearing leukocytes (HRL). I. Detection of histamine receptor-bearing cells by rosette formation with histamine-coated erythrocytes.
    Kedar E; Bonavida B
    J Immunol; 1974 Nov; 113(5):1544-52. PubMed ID: 4213629
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
    Röllinghoff M; Wagner H
    Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the anti-plasma cell serum. II. Morphological studies on the effect of anti-plasma cell serum in mice.
    Hirokawa K; Nariuchi H; Usui M; Matuhasi T
    Jpn J Exp Med; 1972 Jun; 42(3):239-48. PubMed ID: 4538155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.